name | 阮孟德 |
sex | male
|
age | 75 岁 |
hospital number | 512503 |
height | 172 cm |
weight | 60 kg |
BSA | 1.71 m2 |
APACHEⅡ | 36 分 |
Infection source | abdominal
|
date | 2017/05/25 年/月/日 |
Sequential Organ Failure Assessment | 12 分 |
Fluid resuscitation |
age>=60 | yes
|
septic shock | yes
|
mechanical ventilation | |
Early fluid resuscitation | no
|
age<60 | no
|
Pregnant woman | no
|
advanced malignant tumor | no
|
Pulmonary interstitial fibrosis | no
|
Serious arrhythmia | no
|
Small Tidal Volume Ventilation | no
|
Liver failure | no
|
Refuse to participate | no
|
Heart disease | no
|
yes
|
|
no
|
|
no
|
|
no
|
|
no
|
- vital signs
- Blood Gas Analysis
- vasoactive agent and fluid
- PiCCO parameters
- Cardiac Ultrasound
- lung ultrasound
- inferior vena cava
yes
|
|
泰能 0.5g q6h |
|
vasoactive agent | norepinephrine
|
30 min |
|
min |
|
30 min |
Temperature | 39.8 ℃ |
Heart Rate | 163 次/分 |
Breath | 32 次/分 |
Systolic pressure (SP) | 112 mmHg |
Diastolic pressure | 67 mmHg |
mean arterial pressure | 85 mmHg |
Pcv-aCO2 | 6.3 mmHg |
DO2 | 856.8 |
VO2 | 219.4 |
Ca-vO2 | 38.8 |
pH value | 7.47 |
PaO2 | 118.5 mmHg |
PaCO2 | 29.4 mmHg |
BE | -4 mmol/L(±2.3mmol/L) |
SaO2 | 98 % |
Blood lactic acid concentration, LAC | 4.4 mmol/L |
Oxygenation index (PaO2/FiO2) | 357.57 mmHg |
pH value | 7.43 |
PcvO2 | 39.3 mmHg |
PcvCO2 | 35.7 mmHg |
BE | -3 mmol/L |
ScvO2 | 73 % |
Volume of input | 2000 ml |
Volume of output | 300 ml |
Volume of urine | 300 ml |
ultrafiltration volume | 0 ml |
norepinephrine | yes
|
Norepinephrine Dosage | 0.28 μg/Kg/min |
dopamine | no
|
Dopamine Dosage | μg/Kg/min |
Dobutamine | No
|
Dobutamine Dosage | μg/Kg/min |
Milrinone
|
CVP | 9 mmHg |
cardiac output | 5.66 L/min |
cardiac index | 3.31 L/min/m2 |
stroke volume | 34.7 ml |
Stroke Index | 20.3 ml/m2 |
ITBVI | 1198 ml/m2 |
GEDVI | 959 ml/m2 |
EVLWI | 10.8 ml/kg |
PVPI | 1.7 |
SVRI | 1546 DSm2/cm5 |
CFI | 3.2 |
GEF | 8 % |
SVV | % |
PPV | % |
dPmax | 780 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
the number of B line | 56 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 2.2 mm |
IVC(expiratory phase) | 2.2 mm |
respiratory variations of inferior vena cavae diameter | 0 % |
2.3 mm |
|
mm |
|
2.3 mm |
|
mm |
- Inferior Vena Cava
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
IVC(inspiratory phase) | 2.3 mm |
IVC(expiratory phase) | 2.32 mm |
Respiratory variations of inferior vena cavae diameter | 1 % |
2.2 mm |
|
mm |
|
2.25 mm |
|
mm |
Temperature | 36.5 ℃ |
Heart Rate | 95 次/分 |
Breath | 26 次/分 |
Systolic Pressure | 114 mmHg |
Diastolic Pressure | 82 mmHg |
Mean Arterial Pressure | 95 mmHg |
Pcv-aCO2 | 13.1 mmHg |
DO2 | 753.7 |
VO2 | 179.6 |
Ca-vO2 | 36.7 |
PH value | 7.38 |
PaO2 | 129.2 mmHg |
PaCO2 | 29.7 mmHg |
BE | -6 mmol/L |
SaO2 | 98.7 % |
Blood Lactic Acid Concentration | 3.2 mmol/L |
Oxygenation index (PaO2/FiO2) | 390 mmHg |
PH value | 7.31 |
PcvO2 | 36.8 mmHg |
PcvCO2 | 42.8 mmHg |
BE | -4.6 mmol/L |
ScvO2 | 75.3 % |
Volume of input | 2600 ml |
Volume of output | 500 ml |
Volume of urine | 900 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 6 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | 5 mg |
Levosimendan | no
|
CVP | 12 mmHg |
cardiac output | 4.9 L/min |
cardiac index | 2.87 L/min/m2 |
stroke volume | 50.0 ml |
Stroke Index | 29.2 ml/m2 |
ITBVI | 1314 ml/m2 |
GEDVI | 1051 ml/m2 |
EVLWI | 10.3 ml/kg |
PVPI | 1.4 |
SVRI | 2679 DSm2/cm5 |
CFI | 2.5 |
GEF | 11 % |
SVV | 29 % |
PPV | % |
dPmax | 283 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 56 条 |
LUS | 分 |
B+ Zone | 区 |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.6 ℃ |
Heart Rate | 97 次/分 |
Breath | 20 次/分 |
Systolic Pressure | 127 mmHg |
Diastolic Pressure | 71 mmHg |
Mean Arterial Pressure | 94 mmHg |
Pcv-aCO2 | 5.3 mmHg |
DO2 | 962.5 |
VO2 | 173.7 |
Ca-vO2 | 28.3 |
PH value | 7.36 |
PaO2 | 112 mmHg |
PaCO2 | 35.5 mmHg |
BE | -5.2 mmol/L |
SaO2 | 98.1 % |
Blood Lactic Acid Concentration | 2.4 mmol/L |
Oxygenation index (PaO2/FiO2) | 339.3 mmHg |
PH value | 7.32 |
PcvO2 | 38.2 mmHg |
PcvCO2 | 40.8 mmHg |
BE | -4.6 mmol/L |
ScvO2 | 80.5 % |
Volume of input | 3080 ml |
Volume of output | 900 ml |
Volume of urine | 900 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 10 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | 10 mg |
Levosimendan | no
|
CVP | 10 mmHg |
cardiac output | 6.14 L/min |
cardiac index | 3.59 L/min/m2 |
stroke volume | 63.3 ml |
Stroke Index | 37 ml/m2 |
ITBVI | 1326 ml/m2 |
GEDVI | 1061 ml/m2 |
EVLWI | 9.0 ml/kg |
PVPI | 1.3 |
SVRI | 1759 DSm2/cm5 |
CFI | 3.2 |
GEF | 13 % |
SVV | % |
PPV | % |
dPmax | 1018 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 40 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 2.2 mm |
IVC(expiratory phase) | 2.4 mm |
Respiratory variations of inferior vena cavae diameter | 8 % |
2.3 mm |
|
mm |
|
2.4 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 36.8 ℃ |
Heart Rate | 110 次/分 |
Breath | 20 次/分 |
Systolic Pressure | 131 mmHg |
Diastolic Pressure | 76 mmHg |
Mean Arterial Pressure | 97 mmHg |
Pcv-aCO2 | 3.8 mmHg |
DO2 | 905.3 |
VO2 | 152.3 |
Ca-vO2 | 27.2 |
PH value | 7.34 |
PaO2 | 92.4 mmHg |
PaCO2 | 36.3 mmHg |
BE | -5.3 mmol/L |
SaO2 | 97.3 % |
Blood Lactic Acid Concentration | 2.2 mmol/L |
Oxygenation index (PaO2/FiO2) | 280 mmHg |
PH value | 7.32 |
PcvO2 | 38.3 mmHg |
PcvCO2 | 40.1 mmHg |
BE | -4.7 mmol/L |
ScvO2 | 81 % |
Volume of input | 3486 ml |
Volume of output | 1495 ml |
Volume of urine | 1495 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 20 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | 20 mg |
Levosimendan | no
|
CVP | 13 mmHg |
cardiac output | 5.59 L/min |
cardiac index | 3.27 L/min/m2 |
stroke volume | 45.1 ml |
Stroke Index | 26.4 ml/m2 |
ITBVI | 1137 ml/m2 |
GEDVI | 911 ml/m2 |
EVLWI | 9.7 ml/kg |
PVPI | 1.6 |
SVRI | 2299 DSm2/cm5 |
CFI | 3.4 |
GEF | 12 % |
SVV | 27 % |
PPV | % |
dPmax | 905 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 42 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 1.9 mm |
IVC(expiratory phase) | 2.3 mm |
Respiratory variations of inferior vena cavae diameter | 19 % |
2.0 mm |
|
mm |
|
2.3 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.7 ℃ |
Heart Rate | 104 次/分 |
Breath | 20 次/分 |
Systolic Pressure | 117 mmHg |
Diastolic Pressure | 72 mmHg |
Mean Arterial Pressure | 90 mmHg |
Pcv-aCO2 | 0.8 mmHg |
DO2 | 530.8 |
VO2 | 89.5 |
Ca-vO2 | 24.3 |
PH value | 7.40 |
PaO2 | 123.7 mmHg |
PaCO2 | 39.5 mmHg |
BE | -0.3 mmol/L |
SaO2 | 98.5 % |
Blood Lactic Acid Concentration | 1.8 mmol/L |
Oxygenation index (PaO2/FiO2) | 372 mmHg |
PH value | 7.39 |
PcvO2 | 49.9 mmHg |
PcvCO2 | 40.7 mmHg |
BE | -0.4 mmol/L |
ScvO2 | 82 % |
Volume of input | 6715 ml |
Volume of output | 5300 ml |
Volume of urine | 5300 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 52 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | 40 mg |
Levosimendan | no
|
CVP | 8 mmHg |
cardiac output | 3.68 L/min |
cardiac index | 2.15 L/min/m2 |
stroke volume | 35.4 ml |
Stroke Index | 20.7 ml/m2 |
ITBVI | 860 ml/m2 |
GEDVI | 688 ml/m2 |
EVLWI | 7.2 ml/kg |
PVPI | 1.5 |
SVRI | 3647 DSm2/cm5 |
CFI | 2.9 |
GEF | 12 % |
SVV | % |
PPV | % |
dPmax | 679 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 28 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(inspiratory phase) | 1.6 mm |
IVC(expiratory phase) | 2.0 mm |
Respiratory variations of inferior vena cavae diameter | 22 % |
1.7 mm |
|
mm |
|
2.1 mm |
|
mm |
- Vital Signs
- Blood Gas Analysis
- Vasoactive Agent and Fluid
- PiCCO Parameters
- Cardiac Ultrasound
- Lung Ultrasound
- Inferior Vena Cava
Temperature | 37.5 ℃ |
Heart Rate | 103 次/分 |
Breath | 25 次/分 |
Systolic Pressure | 123 mmHg |
Diastolic Pressure | 76 mmHg |
Mean Arterial Pressure | 96 mmHg |
Pcv-aCO2 | 2 mmHg |
DO2 | 801.6 |
VO2 | 145.3 |
Ca-vO2 | 24.7 |
PH value | 7.42 |
PaO2 | 101.7 mmHg |
PaCO2 | 40.3 mmHg |
BE | 0.4 mmol/L |
SaO2 | 97.6 % |
Blood Lactic Acid Concentration | 1.9 mmol/L |
Oxygenation index (PaO2/FiO2) | 306 mmHg |
PH value | 7.41 |
PcvO2 | 42.5 mmHg |
PcvCO2 | 38.3 mmHg |
BE | 0.6 mmol/L |
ScvO2 | 80 % |
Volume of input | 10344 ml |
Volume of output | 8625 ml |
Volume of urine | 8625 ml |
Ultrafiltration Volume | 0 ml |
Norepinephrine Dosage | 72 mg |
Dopamine Dosage | mg |
Epinephrine Dosage | mg |
Pituitrin Dosage | U |
Dobutamine Dosage | mg |
Milrinone Dosage | 60 mg |
Levosimendan | no
|
CVP | 8 mmHg |
cardiac output | 5.88 L/min |
cardiac index | 3.44 L/min/m2 |
stroke volume | 57.1 ml |
Stroke Index | 33.4 ml/m2 |
ITBVI | 1153 ml/m2 |
GEDVI | 923 ml/m2 |
EVLWI | 7.2 ml/kg |
PVPI | 1.2 |
SVRI | 2093 DSm2/cm5 |
CFI | 3.5 |
GEF | 14 % |
SVV | 22 % |
PPV | % |
dPmax | 735 |
LVEF | % |
FS | % |
SV | ml |
CO | L/min |
E peak |
|
A peak |
|
E/A |
|
Ea(ventricular septum) |
|
Ea(lateral wall) |
|
E/Ea(ventricular septum) |
|
E/Ea(lateral wall) |
|
MAPSE | mm |
TAPSE | mm |
RV size | |
LVEDV | ml |
LVEDD | cm |
The number of B line | 18 条 |
LUS | 分 |
B+ Zone | 区 |
IVC(expiratory phase) | 1.8 mm |
Respiratory variations of inferior vena cavae diameter | 2.2 % |
IVC(inspiratory phase) | 20 mm |
1.6 mm |
|
mm |
|
2.1 mm |
|
mm |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 675 pg/ml |
cTNI | 0.48 ng/ml |
Creatine kinase isoenzyme, CKMB | 5.6 U/L |
Creatinine | 151 umol/L |
Urea nitrogen | 8.9 mmol/l |
MDRD | ml/min/1.73m2 |
Date of examination | yyyy-mm-dd |
WBC | 23.7 X10*9/L |
neutrophilic granulocyte percentage | 95.3 % |
Hb | 115 g/L |
CRP | 177 mg/L |
Procalcitonin, PCT | 大于100 ng/ml |
Date of test |
|
Sequential Organ Failure Assessment | 12 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 196 pg/ml |
cTNI | 0.15 ng/ml |
Creatine kinase isoenzyme, CKMB | 6 U/L |
Creatinine | 181 umol/L |
Urea nitrogen | 13.4 mmol/l |
MDRD | ml/min/1.73m2 |
WBC | 41.6 X10*9/L |
neutrophilic granulocyte percentage | 94.5 % |
Hb | 124 g/L |
CRP | 342 mg/L |
Procalcitonin, PCT | 大于100 ng/ml |
Sequential Organ Failure Assessment | 12 分 |
- Cardiac Function Indices
- Renel Function Indices
- Blood Routine Tests
- Sequential Organ Failure Assessment
NT-proBNP | pg/ml |
BNP | 105 pg/ml |
cTNI | 0.05 ng/ml |
Creatine kinase isoenzyme, CKMB | 4 U/L |
Creatinine | 166 umol/L |
Urea nitrogen | 15.1 mmol/L |
MDRD | ml/min/1.73m2 |
WBC | 25.6 X10*9/L |
neutrophilic granulocyte percentage | 93.9 % |
Hb | 109 g/L |
CRP | 229 mg/L |
Procalcitonin, PCT | 39.4 ng/ml |
Sequential Organ Failure Assessment | 10 分 |
Transfusion of Red Cells | no
|
Transfusion of Red Cells | U |
Plasma infusion | no
|
Plasma infusion | ml |
platelet transfusion | no
|
platelet transfusion | U |
APACHEⅡ | 20 分 |
Complication |
prognosis | department transference
|
28-day mortality | |
survival time(day) | 天 |
death time | yyyy/mm/dd |
diagnosis of death |
|
length of stay | 天 |
duration in ICU | 6 天 |
duration of mechanical ventilation | 0 小时 |
ICU expenses | 4166 元 |
Continuous Renal Replacement Therapy | no
|
Continuous Renal Replacement Therapy | 小时 |